Abstract
There is limited knowledge of risk factors for breast cancer recurrence within 2 years. This study aimed to predict early failure and identify high-risk patients for prognostic and therapeutic purposes. We studied 739 patients from a randomized trial who were <56 years of age and had >/=4 or more positive lymph nodes, no distant metastases, and no previous other malignancies. After complete surgical treatment, patients received conventional-dose anthracycline-based chemotherapy or a high-dose scheme of anthracycline-based plus alkylating chemotherapy. We assessed clinical and (immuno)histological parameters to predict recurrence within 2 years. Early failure occurred in 19% (n = 137). Median survival after early failure was limited to 0.7 year. Estrogen and progesterone receptor negativity and visceral relapse predicted poor prognosis. Early failure was associated with young age, large tumors, high histological grade, angio-invasion, apical node metastasis, and >/=10 involved nodes. Estrogen receptor, progesterone receptor, and p27 negativity; HER2 overexpression; and p53 positivity also predicted early failure. The surgical or chemotherapy regimen and histological type did not. The same parameters except tumor size were associ...Continue Reading
References
Nov 1, 1991·Histopathology·C W Elston, I O Ellis
Apr 15, 1990·Cancer·H TsudaH Yamamoto
Sep 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockH Sutherland
May 12, 1989·Science·D J SlamonA Ullrich
Jan 1, 1989·Acta Oncologica·S R EbbsM Baum
Jan 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A GoldhirschM Castiglione
Oct 1, 1987·British Journal of Cancer·J Carmo-PereiraR D Rubens
Jan 9, 1987·Science·D J SlamonW L McGuire
Nov 1, 1983·Cancer·B FisherR Margolese
Feb 12, 1994·Lancet·A GoldhirschG Marini
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R SeshadriP Kitchen
Jul 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C FocanF Ries
Feb 3, 1993·Journal of the National Cancer Institute·D C AllredW L McGuire
Sep 1, 1995·Genes, Chromosomes & Cancer·A L BørresenS Hartman
Oct 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S ThorlaciusJ E Eyfjörd
Jan 1, 1996·Cancer·M ChungH J Wanebo
Jul 1, 1996·Nature Medicine·T AasP E Lønning
Jan 1, 1997·British Journal of Cancer·J KolliasR W Blamey
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·S FredersdorfX Lu
Aug 26, 1998·Lancet·S RodenhuisE Rutgers
Mar 5, 1999·Breast Cancer Research and Treatment·S CariouJ M Slingerland
Jan 11, 2001·Oncology·T NoharaN Tanigawa
Mar 16, 2001·Breast Cancer Research : BCR·R ChiarleG Inghirami
Feb 22, 2002·Cancer·Ashutosh S KothariIan S Fentiman
Jun 6, 2002·American Journal of Clinical Pathology·Elise R HoffGary W Procop
Sep 3, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·I FredrikssonJ Frisell
Feb 6, 2003·British Journal of Cancer·I F FaneyteM J van de Vijver
Jul 4, 2003·The New England Journal of Medicine·Sjoerd RodenhuisUNKNOWN Netherlands Working Party on Autologous Transplantation in Solid Tumors
Citations
Feb 8, 2008·Cancer Chemotherapy and Pharmacology·Rupert BartschGuenther G Steger
Sep 22, 2009·Breast Cancer Research and Treatment·Antoaneta TomovaChristoph C Zielinski
Feb 15, 2011·Breast Cancer Research and Treatment·Oleg GluzAndreas Gaumann
Mar 28, 2008·Current Oncology Reports·Alice Ulhoa-CintraCharles E Geyer
Apr 15, 2010·Medical Oncology·Gul BasaranSerdar N Turhal
May 3, 2012·Pathology Oncology Research : POR·Beata BiesagaMarek Ziobro
Nov 13, 2004·Breast Cancer Research : BCR·Anthony Howell
Apr 4, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Rupert BartschGuenther G Steger
Aug 6, 2009·Expert Opinion on Biological Therapy·Rupert Bartsch, Guenther G Steger
Jan 9, 2008·Cancer Investigation·Jeffrey PeppercornLisa A Carey
Sep 15, 2009·Cancer Treatment Reviews·D CollinsL Young
Sep 16, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Germaine WongJonathan C Craig
Aug 19, 2007·The Breast : Official Journal of the European Society of Mastology·Sara M Tolaney, Eric P Winer
Jun 19, 2008·International Journal of Cancer. Journal International Du Cancer·Oleg GluzArndt Hartmann
Dec 19, 2007·The Breast Journal·Francesca HoehneArmando E Giuliano
Nov 18, 2005·The Breast : Official Journal of the European Society of Mastology·Jeffery PeppercornEric P Winer
Jul 18, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Ai-Na LiuLiang-Ming Zhang
Feb 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marianne KyndiUNKNOWN Danish Breast Cancer Cooperative Group
Aug 8, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rupert BartschGuenther G Steger
Jan 5, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O GluzUNKNOWN West German Study Group
Mar 28, 2017·Scientific Reports·Esther Paredes-AracilVicente Francisco Gil-Guillén
Aug 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rupert BartschGuenther G Steger
Sep 3, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin FilipitsUNKNOWN Austrian Breast and Colorectal Cancer Study Group
May 22, 2019·Seminars in Cell & Developmental Biology·Tânia CapelôaPierre Sonveaux